Federation Des Caisses Desjardins Du Quebec Gilead Sciences, Inc. Transaction History

Federation Des Caisses Desjardins Du Quebec

$23.7 Billion
Q3 2025

A detailed history of Federation Des Caisses Desjardins Du Quebec transactions in Gilead Sciences, Inc. stock. As of the latest transaction made, Federation Des Caisses Desjardins Du Quebec holds 118,482 shares of GILD stock, worth $14.7 Million. This represents 0.06% of its overall portfolio holdings.

Number of Shares

118,482

Previous 100,032 18.44%

Holding current value

$14.7 Million

Previous $11.1 Million 18.58%

% of portfolio

0.06%

Previous 0.05%

35 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2025 Nov 14, 2025	BUY	$108.22 - $120.47 $2 Million - $2.22 Million	18,450 Added 18.44%	118,482 $13.2 Million
Q2 2025 Aug 14, 2025	BUY	$96.91 - $113.0 $474,568 - $553,361	4,897 Added 5.15%	100,032 $11.1 Million
Q1 2025 May 15, 2025	BUY	$89.14 - $117.41 $585,025 - $770,561	6,563 Added 7.41%	95,135 $10.7 Million
Q4 2024 Feb 13, 2025	BUY	$83.95 - $97.9 $2.32 Million - $2.71 Million	27,695 Added 45.49%	88,572 $8.18 Million
Q3 2024 Nov 13, 2024	SELL	$66.59 - $83.99 $770,912 - $972,352	-11,577 Reduced 15.98%	60,877 $5.1 Million

Q2 2024 Aug 14, 2024	SELL	$63.15 - $72.88 $471,351 - $543,976	-7,464 Reduced 9.34%	72,454 $4.97 Million
Q1 2024 May 15, 2024	BUY	$71.58 - $87.29 $5.72 Million - $6.98 Million	79,918 New	79,918 $6.09 Billion
Q4 2023 Aug 14, 2024	BUY	$73.27 - $83.09 $844,876 - $958,110	11,531 Added 40.62%	39,919 $3.23 Billion
Q3 2023 Aug 14, 2024	SELL	$73.94 - $80.67 $207,697 - $226,602	-2,809 Reduced 9.0%	28,388 $2.13 Billion
Q2 2023 Aug 14, 2024	BUY	$76.01 - $86.7 $697,011 - $795,039	9,170 Added 41.63%	31,197 $2.4 Billion
Q1 2023 Aug 14, 2024	SELL	$77.31 - $88.08 $2.55 Million - $2.9 Million	-32,945 Reduced 59.93%	22,027 $1.83 Billion
Q4 2022 Aug 14, 2024	SELL	$62.32 - $89.47 $937,043 - $1.35 Million	-15,036 Reduced 21.48%	54,972 $4.72 Billion
Q3 2022 Aug 14, 2024	BUY	$59.54 - $68.01 $1.04 Million - $1.19 Million	17,534 Added 33.41%	70,008 $4.32 Billion
Q2 2022 Aug 14, 2024	BUY	$57.72 - $65.01 $283,174 - $318,939	4,906 Added 10.31%	52,474 $3.24 Billion
Q1 2022 Aug 14, 2024	SELL	$57.92 - $72.58 $1.44 Million - $1.81 Million	-24,886 Reduced 34.35%	47,568 $2.83 Billion
Q4 2021 Aug 30, 2024	BUY	$64.88 - $73.64 $1.81 Million - $2.05 Million	27,842 Added 184.59%	42,925 $3.12 Billion
Q3 2021 Aug 30, 2024	SELL	$67.69 - $73.03 $84,003 - $90,630	-1,241 Reduced 7.6%	15,083 $1.05 Billion
Q2 2021 Aug 30, 2024	SELL	$63.47 - $69.35 $3.56 Million - $3.89 Million	-56,130 Reduced 77.47%	16,324 $1.12 Billion
Q1 2021 Aug 30, 2024	SELL	$60.0 - $68.46 $5.31 Million - $6.06 Million	-88,476 Reduced 43.8%	113,501 $7.34 Billion
Q4 2020 Aug 30, 2024	BUY	$56.65 - $64.55 $1.26 Million - $1.43 Million	22,159 Added 12.32%	201,977 $11.8 Billion
Q3 2020 Aug 30, 2024	BUY	$62.1 - $78.08 $10.5 Million - $13.2 Million	168,698 Added 1517.07%	179,818 $11.4 Billion
Q2 2020 Aug 30, 2024	SELL	$72.34 - $84.0 $29,153 - $33,852	-403 Reduced 3.5%	11,120 $856 Million
Q1 2020 Aug 30, 2024	SELL	$62.63 - $80.22 $1.73 Million - $2.22 Million	-27,625 Reduced 70.57%	11,523 $861 Million
Q4 2019 Aug 30, 2024	SELL	$61.62 - $67.78 $228,425 - $251,260	-3,707 Reduced 8.65%	39,148 $2.54 Billion
Q3 2019 Aug 30, 2024	SELL	$62.51 - $69.0 $56,008 - $61,824	-896 Reduced 2.05%	42,855 $2.72 Billion
Q2 2019 Aug 30, 2024	SELL	$61.87 - $69.38 $447,753 - $502,103	-7,237 Reduced 14.19%	43,751 $2.96 Billion
Q1 2019 Aug 30, 2024	BUY	$62.53 - $70.05 $17,508 - $19,614	280 Added 0.55%	50,988 $3.31 Billion
Q4 2018 Aug 30, 2024	SELL	$60.54 - $79.0 $1.32 Million - $1.72 Million	-21,746 Reduced 30.01%	50,708 $3.17 Billion
Q3 2018 Aug 30, 2024	SELL	$71.28 - $78.92 $3.76 Million - $4.16 Million	-52,745 Reduced 41.93%	73,037 $5.64 Billion
Q2 2018 Aug 30, 2024	BUY	$64.88 - $75.68 $4.83 Million - $5.63 Million	74,380 Added 144.7%	125,782 $8.92 Billion
Q1 2018 Aug 30, 2024	SELL	$72.84 - $88.8 $1.18 Million - $1.44 Million	-16,164 Reduced 23.92%	51,402 $3.88 Billion
Q4 2017 Aug 30, 2024	SELL	$71.15 - $83.52 $38,990 - $45,768	-548 Reduced 0.8%	67,566 $4.84 Billion
Q3 2017 Aug 30, 2024	SELL	$72.11 - $85.47 $599,594 - $710,683	-8,315 Reduced 10.88%	68,114 $5.52 Billion
Q2 2017 Aug 30, 2024	SELL	N/A	-15,587 Reduced 16.94%	76,429 $5.41 Billion
Q1 2017 Aug 30, 2024	BUY	N/A	19,562	92,016 $6.25 Billion

Others Institutions Holding GILD

# of Institutions

2,376

Shares Held

1.01B

Call Options Held

8.58M

Put Options Held

7.35M

View Full List

About GILEAD SCIENCES, INC.

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $156B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

More about GILD

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Federation Des Caisses Desjardins Du Quebec, based on Form 13F filings with the SEC.

News

Stay updated on Federation Des Caisses Desjardins Du Quebec with notifications on news.

Account

Federation Des Caisses Desjardins Du Quebec Gilead Sciences, Inc. Transaction History